784181-33-5

Upstream product

• 1174629-11-8 ethyl 1-(2-chlorophenyl)-5-(4-chlorophenyl)-4-hydroxymethyl-1H-pyrazole-3-carboxylate 
• 851728-85-3 ethyl 1-(2-chlorophenyl)-5-(4-chlorophenyl)-4-vinyl-1H-pyrazole-3-carboxylate 

Downstream Products

• 784181-19-7 5-(4-chloro-phenyl)-1-(2-chloro-phenyl)-4-[2-(2-trimethylsilanyl-ethoxy)-vinyl]-1H-pyrazole-3-carboxylic acid ethyl ester 
• 1174629-12-9 1-(2-chlorophenyl)-5-(4-chlorophenyl)-4-formyl-1H-pyrazole-3-carboxylic acid 
• 851728-86-4 ethyl 5-(4-chlorophenyl)-1-(2-chlorophenyl)-4-hydroxy-1H-pyrazole-3-carboxylate 

Relevant academic research and scientific papers

FUSED PYRAZOLE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS

The present invention relates to novel cannabinoid receptor modulators of formula (I), in particular cannabinoid 1 (CB1) or cannabinoid 2 (CB2) receptor modulators, and uses thereof for treating diseases, conditions and/or disorders modulated by a cannabi

Acylaminobicyclic heteroaromatic compounds and uses thereof

Compounds of Formula (I) are described herein. The compounds have been shown to act as cannabinoid receptor ligands and are therefore useful in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals.

Bicyclic pyrazolyl and imidazolyl compounds and uses thereof

Compounds of Formula (I) are described herein. The compounds have been shown to act as cannabinoid receptor ligands and are therefore useful in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals.